Last reviewed · How we verify
NCT07443033: DUAL-HVP
Psychosocial Factors in Dual Diagnosis in a General Hospital
trial in Dual Diagnosis in 125 participants. Not yet recruiting.
30 April 2027
Quick facts
| Lead sponsor | Hospital Virgen del Puerto |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 125 |
| Start date | 1 March 2026 |
| Primary completion | 30 April 2027 |
| Estimated completion | 30 April 2027 |
| Sites | 1 location across Spain |
Conditions studied
- Dual Diagnosis — all drugs for Dual Diagnosis →
- Substance Use Disorder — all drugs for Substance Use Disorder →
- Mental Disorders — all drugs for Mental Disorders →
Sponsor
Hospital Virgen del Puerto
Who can join
18 and older, any sex, with Dual Diagnosis or Substance Use Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Dual diagnosis, defined as the co-occurrence of a mental disorder and a substance use disorder, is frequently associated with increased clinical severity, functional impairment, and poorer health outcomes. Identifying psychosocial protective factors related to better clinical and functional outcomes is essential to improve patient care and treatment planning. The aim of this observational, cross-sectional, single-center study is to analyze psychosocial protective factors and their association with clinical-functional outcomes in hospitalized patients with dual diagnosis. The study will be conducted in a general hospital setting and will include adult inpatients diagnosed with dual diagnosis according to clinical criteria. Sociodemographic, clinical, and psychosocial variables will be collected using standardized assessment tools and clinical records. The results of this study are expected to contribute to a better understanding of psychosocial factors associated with clinical severity and functional outcomes in patients with dual diagnosis, supporting more comprehensive and patient-centered care approaches.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07443033
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Dual Diagnosis
Currently open trials in the same condition.
- NCT06311838 — Building Social and Structural Connections for the Prevention of Opioid Use Disorder Among Youth Experiencing Homelessne · NA · recruiting
- NCT05054738 — CRP and S&A for Inpatient Veterans · NA · recruiting
- NCT04105231 — Cannabidiol for Treatment of Non-affective Psychosis and Cannabis Use · Phase 2 · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07443033 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Virgen del Puerto
- Last refreshed: 2 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07443033.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing